Pulmonary Embolism Clinical Trial
Official title:
Registry of Angiovac Procedures In Detail Outcomes Database
Venous thromboembolic disease is a significant cause of morbidity and mortality. The purpose of the RAPID registry is to collect information on the Angiovac procedure and Angiovac device used in the treatment of deep venous thrombosis (DVT), right heart pathology and pulmonary embolism.
Venous thromboembolic disease is a significant cause of morbidity and mortality. Thrombolytic
therapy has been shown to be a successful treatment modality, however its use is somewhat
limited due to the known risk of hemorrhage (overall 22%, with up to 3% intracranial
hemorrhage), and suggested risk of distal embolization where large mobile thrombi are
encountered. In patients where either thrombolysis is contraindicated or unsuccessful and
conventional therapies inadequate, bulk thrombectomy may be considered. Until recently this
was primarily achieved with surgical thrombectomy; however the Angiovac device is posited to
offer a minimally invasive alternative.
This registry will collect data on patients in whom the Angiovac device was placed into the
body for management of inferior vena cava (IVC) clots, right atrial (RA) masses or pulmonary
emboli (PE) will be included.
This registry is to capture high quality patient safety and effectiveness data on use of the
Angiovac device for 3 separate, but overlapping conditions; a) Iliofemoral and Caval DVT, b)
Right heart masses, and c) PE. The goal will be achieved by capturing a concise set of
immediate and short-term functional and clinical outcome data for all patients who have the
angiovac catheter deployed into the vascular system.
Any center performing Angiovac procedure and wishing to contribute patient data will be
offered participation in the registry. These core sites will be required to submit the
registry protocol for Institutional Review Board (IRB) review. Once documentation of IRB
approval has been received, centers may transmit their data via secure REDCap (Research
Electronic Data Capture) database in accordance with federal regulations in the Health
Insurance Portability and Accountability Act (HIPAA
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05050617 -
Point-of-Care Ultrasound in Predicting Adverse Outcomes in Emergency Department Patients With Acute Pulmonary Embolism
|
||
Terminated |
NCT04558125 -
Low-Dose Tenecteplase in Covid-19 Diagnosed With Pulmonary Embolism
|
Phase 4 | |
Not yet recruiting |
NCT06017271 -
Predictive Value of Epicardial Adipose Tissue for Pulmonary Embolism and Death in Patients With Lung Cancer
|
||
Completed |
NCT03915925 -
Short-term Clinical Deterioration After Acute Pulmonary Embolism
|
||
Completed |
NCT02502396 -
Rivaroxaban Utilization for Treatment and Prevention of Thromboembolism in Cancer Patients: Experience at a Comprehensive Cancer Center
|
||
Recruiting |
NCT05171075 -
A Study Comparing Abelacimab to Dalteparin in the Treatment of Gastrointestinal/Genitourinary Cancer and Associated VTE
|
Phase 3 | |
Completed |
NCT04454554 -
Prevalence of Pulmonary Embolism in Patients With Dyspnea on Exertion (PEDIS)
|
||
Completed |
NCT03173066 -
Ferumoxytol as a Contrast Agent for Pulmonary Magnetic Resonance Angiography
|
Phase 1 | |
Terminated |
NCT03002467 -
Impact Analysis of Prognostic Stratification for Pulmonary Embolism
|
N/A | |
Completed |
NCT02334007 -
Extended Low-Molecular Weight Heparin VTE Prophylaxis in Thoracic Surgery
|
Phase 1/Phase 2 | |
Completed |
NCT02611115 -
Optimizing Protocols for the Individual Patient in CT Pulmonary Angiography.
|
N/A | |
Completed |
NCT01975090 -
The SENTRY Clinical Study
|
N/A | |
Not yet recruiting |
NCT01357941 -
Need for Antepartum Thromboprophylaxis in Pregnant Women With One Prior Episode of Venous Thromboembolism (VTE)
|
N/A | |
Completed |
NCT01326507 -
Prognostic Value of Heart-type Fatty Acid-Binding Protein (h-FABP) in Acute Pulmonary Embolism
|
N/A | |
Completed |
NCT00771303 -
Ruling Out Pulmonary Embolism During Pregnancy:a Multicenter Outcome Study
|
||
Completed |
NCT00780767 -
Angiojet Rheolytic Thrombectomy in Case of Massive Pulmonary Embolism
|
Phase 2 | |
Completed |
NCT02476526 -
Safety of Low Dose IV Contrast CT Scanning in Chronic Kidney Disease
|
Phase 4 | |
Completed |
NCT00720915 -
D-dimer to Select Patients With First Unprovoked Venous Thromboembolism Who Can Have Anticoagulants Stopped at 3 Months
|
N/A | |
Completed |
NCT00773448 -
Screening for Occult Malignancy in Patients With Idiopathic Venous Thromboembolism
|
N/A | |
Completed |
NCT00816920 -
Natural History of Isolated Deep Vein Thrombosis of the Calf
|